Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

35.83
Delayed Data
As of 4:00pm ET
 -0.37 / -1.02%
Today’s Change
29.83
Today|||52-Week Range
36.60
+10.31%
Year-to-Date
What to Expect from Big Pharmas After J&J's Solid Q3 Results?
4:54pm / Zacks.com - Paid Partner Content
Reckitt restructures after second sales warning of year
3:57am / FT.com - Paid Partner Content
Reckitt boss hopes to feel no pain after doing the splits
3:12pm / FT.com - Paid Partner Content
Sabal Trust CO Buys United Parcel Service Inc, Bristol-Myers Squibb Company, Hanesbra...
Oct 17 / GuruFocus News - Paid Partner Content
Biogen (BIIB) Q3 Earnings: Will it Deliver a Beat Again?
10:08am / Zacks.com - Paid Partner Content
Aerie (AERI) Up on FDA Review Committee Result for Rhopressa
Oct 17 / Zacks.com - Paid Partner Content
Reckitt Benckiser: fission for compliments
9:28am / FT.com - Paid Partner Content
Dow Jones and S&P 500 Close at New Highs
Oct 17 / GuruFocus News - Paid Partner Content
Eli Lilly (LLY) to Report Q3 Earnings: What's in Store?
8:20am / Zacks.com - Paid Partner Content
Comprehensive Portfolio Management, LLC Buys PolarityTE Inc, Pfizer Inc, SPDR Nuveen ...
Oct 17 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close36.20
Today’s open36.23
Day’s range35.79 - 36.29
Volume14,417,647
Average volume (3 months)17,279,767
Market cap$215.6B
Dividend yield3.57%
Data as of 4:00pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+6.65%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+8.13%
P/E ratio26.2
Price/Sales3.79
Price/Book3.69

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.30-0.35%
MRKMerck+0.29+0.46%
SNYSanofi-0.06-0.12%
ABBVAbbVie+3.87+4.20%
Data as of 4:02pm ET, 10/18/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$0.64
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts